Structure (Metaprolol 01)
Metoprolol Succinate Tablet, Extended Release
Product Images NDC 72516-028
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 72516-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Oryza Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Metaprolol 02)
50 mg 1000 Count (Metoprolol 09)
This text is a label for a medication containing metoprolol, a drug used to treat high blood pressure and chest pain. The tablet contains 47.5 mg of metoprolol succinate, which is equivalent to 50 mg of metoprolol tartrate. The dosage instructions are provided in the package insert. The medication should be kept out of reach of children and stored at a temperature between 15-30°C (59-86°F). The medication is manufactured by Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. in China for Oryza Pharmaceuticals, Inc. The label also includes contact information for the manufacturer in Coral Springs, FL.*
100 mg 1000 Count (Metoprolol 10)
This text provides information about a medication in the form of tablets containing 95 mg of metoprolol succinate, which is equivalent to 100 mg of metoprolol tartrate, USP. The dosage details are available in the package insert, and a warning to keep the medication out of reach of children. The tablets are to be stored at room temperature with excursions permitted within a certain range. The medication is recommended to be dispensed in a child-resistant container. Additionally, it lists the manufacturer as Oryza Pharmaceuticals, Inc. and the manufacturer's location in China.*
200 mg 100 Count (Metoprolol 11)
This is a description of a medication containing metoprolol succinate, with each tablet containing 190 mg of the active ingredient. It is equivalent to 200 mg of metoprolol tartrate. The dosage information should be referred to in the package insert. The manufacturer is Oryza Pharmaceuticals, Inc. based in Coral Springs, FL, while the manufacturing is done by Zhejlang Apeloa Kangyu Pharmaceutical Co, Ltd. in China. The storage conditions recommend keeping the medication at 25°C (77°F) with excursions allowed to 15-30°C (59-86°F). A warning is provided to keep the medication out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
